Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Butterball Introduces the Butterball® Buddy to Help Guests Bring More to the Table This Thanksgiving
-
Sempreon Officially Debuts as the New Name of MGP Ingredients
-
Lumentum Announces First Quarter of Fiscal Year 2027 Financial Results
-
Bilt Acquires Sports Loyalty Technology Leader LAVA in $300 Million Deal, Signaling Major Expansion Beyond Housing
-
Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation
-
Quantum XChange CEO to Highlight Growing Quantum Threat to Satellite Security at CyberSat 2026
-
Harrow Launches HarrowRx Platform
-
Eldridge Provides Update on Progress at 1 Beverly Hills
-
Graviton BioScience and CinRx Pharma Form CinRock Pharma to Advance ROCK2-Targeted Therapies for Cardiovascular Disease
-
Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate
-
NMG Reaches a Major Regulatory Milestone with the Granting of the Mining Lease by Québec’s Ministry of Natural Resources and Forests for the Matawinie Mine
-
Eptura Names First Chief AI Officer
-
Flowco Holdings Inc. Announces Expansion of Share Repurchase Program
-
All U Need Pest Control Partners with Golden Gate Capital on Recapitalization
-
Yarrow Bioscience Announces Participation in November Investor Events
-
Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
-
Stonepeak Completes Acquisition of Majority Controlling Interest in Castrol From bp
-
Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026 San Antonio Breast Cancer Symposium
-
Caldera Therapeutics Appoints Michelle Doig as Chief Financial Officer and Lee Giguere as Chief Legal Officer
-
AIRO Announces First U.S. Sale of RQ-35 and RQ-70 Unmanned Aircraft Systems
-
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
-
AN2 Therapeutics Receives U.S. FDA IND Clearance to Proceed with Planned Phase 2 Global Study of Oral Epetraborole in Polycythemia Vera
-
Wabtec Secures Approximately $390 Million Services Agreement with Transnet Engineering
-
Benefit Street Partners Announces Closing of a $1.1 Billion CRE CLO
-
Keeper Security Wins Seven Cyber Defense Magazine 2026 Top InfoSec Innovators Awards
-
LIB Therapeutics Sets $300 Monthly List Price for the Autoinjector Form of LEROCHOL® (lerodalcibep-liga), Lowering Costs and Expanding Access for Adults Living With High Cholesterol
-
Introducing TAMKO STRONG™ Program: A Three Pillar Initiative Serving Today's Contractors Who Want to Win
-
Cascadia Capital Appoints Former Cain Brothers Executive Rhett Thurman as CFO
-
Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome
-
Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
-
Tower Semiconductor Reports Third Quarter Record Results, Providing Record Fourth Quarter Guidance Resulting in 2026 $2 Billion Annual Revenue
-
Cipher Digital Provides Third Quarter 2026 Business Update
-
Hinge Bio to Present Latest Results of HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026
-
NorthStrive Acquisition Corp I Announces Business Combination with Nuclea Energy
-
Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
-
SUNation Energy Announces Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Merger with Suniva
-
WRAP Taps Former NYPD Chief Behind Narcan Rollout to Scale BolaWrap and Operationalize De-Escalation
-
Rocket Doctor Expands into Florida, Building Upon Success in California, New York, and Maryland
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
-
Beeline Medicines Initiates First Trial in Lupus Pivotal Development Program with Global Phase 2/3 DISCOVERY Trial of Afimetoran in Cutaneous Lupus Erythematosus (CLE)
-
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
-
Rapport Announces Closing of Public Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Notes,
-
Climb Bio to Present at Guggenheim 3rd Annual Healthcare Innovation Conference
-
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
-
French Level Up Launches DELF B2 and TCF IRN Readiness Check for Citizenship Applicants
-
Vireo Growth to Report Third Quarter 2026 Financial Results on November 10, 2026
-
Southwestern University and City of Georgetown Officially Begin Construction of Southwestern University 560
-
Lightbridge Provides Business Update and Announces Third Quarter Fiscal 2026 Financial Results
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
